Cargando…
Development of a hydrolysis-based small-molecule hydrogen selenide (H(2)Se) donor
Selenium is essential to human physiology and has recently shown potential in the treatment of common pathophysiological conditions ranging from arsenic poisoning to cancer. Although the precise metabolic and chemical pathways of selenium incorporation into biomolecules remain somewhat unclear, many...
Autores principales: | Newton, Turner D., Pluth, Michael D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006510/ https://www.ncbi.nlm.nih.gov/pubmed/32110352 http://dx.doi.org/10.1039/c9sc04616j |
Ejemplares similares
-
Direct hydrogen selenide (H(2)Se) release from activatable selenocarbamates
por: Newton, Turner D., et al.
Publicado: (2023) -
Fluorogenic hydrogen sulfide (H(2)S) donors based on sulfenyl thiocarbonates enable H(2)S tracking and quantification
por: Zhao, Yu, et al.
Publicado: (2018) -
Deposition of MoSe(2) flakes using cyclic selenides
por: Charvot, Jaroslav, et al.
Publicado: (2021) -
Dithioesters: simple, tunable, cysteine-selective H(2)S donors
por: Cerda, Matthew M., et al.
Publicado: (2018) -
Enol-mediated delivery of H(2)Se from γ-keto selenides: mechanistic insight and evaluation
por: Hankins, Rynne A., et al.
Publicado: (2022)